Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / HALB - Halberd launches Halberd Cancer Therapeutics wholly owned subsidiary

HALB - Halberd launches Halberd Cancer Therapeutics wholly owned subsidiary

Tykhe Corp
  • Halberd ( OTCPK:HALB ) has announced the formation of Halberd Cancer Therapeutics, as a wholly owned subsidiary.
  • Halberd's patented extracorporeal technology has demonstrated the capacity for successful application to a wide variety of diseases and health-related illnesses.
  • With this strategy, both Halberd Corporation and Halberd Cancer Therapeutics, LTD will benefit from the initial sharing of technological accomplishments.
  • "We believe that the creation of this subsidiary is a concrete means of advancing the extracorporeal treatment technology against various forms of cancer." said William A. Hartman, Chairman, President & CEO of Halberd.

For further details see:

Halberd launches "Halberd Cancer Therapeutics" wholly owned subsidiary
Stock Information
Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com
Menu
HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...